MW151
MW151 has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Mar 31, 2026: “Glial cytokine modulation improves sleep and circadian disruption in female SAA knock-in mice of Alzheimer's-related pathology”.
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: National Institute on Aging and 1 more
- 3 of 3 findings with company ties
- Animals1
What did studies of MW151 find?
3Studies of MW151 measured 3 outcomes; the most studied are amyloid-beta (1 study), TNF-alpha (1) and sleep (1).
Amyloid-beta
no changein mice1
1 study
Amyloid-beta
no changein mice1
MW151 showed no clear effect on amyloid-beta in mice.
“MW151 increased light-phase sleep and reduced cortical TNF-α without altering amyloid beta (Aβ) accumulation.”
Animalsbrain2.5 mg/kg, every other day6 weeksfemales
Alzheimer's & dementia : the journal of the Alzheimer's Association
TNF-alpha
downin mice1
1 study
TNF-alpha
downin mice1
MW151 decreases TNF-alpha in mice.
“MW151 increased light-phase sleep and reduced cortical TNF-α without altering amyloid beta (Aβ) accumulation.”
Animalscortex2.5 mg/kg, every other day6 weeksfemales
Alzheimer's & dementia : the journal of the Alzheimer's Association
Sleep
upin mice1
1 study
Sleep
upin mice1
MW151 improves sleep in mice.
“MW151 increased light-phase sleep and reduced cortical TNF-α without altering amyloid beta (Aβ) accumulation.”
Animalsbrain2.5 mg/kg, every other day6 weeksfemales
Alzheimer's & dementia : the journal of the Alzheimer's Association